Department of Medicine

Residency in the Department of Medicine

The Stanford University Internal Medicine Residency program is designed to prepare you for any career in Internal Medicine. The program offers broad clinical experience across three hospitals, supportive teaching faculty who are leaders in their fields, a strong esprit de corps, housestaff research opportunities, and top-ranked fellowship and career placement. With these resources, the program enables housestaff to develop excellent clinical skills while attaining long-term career goals.

Program Leadership

 

http://med.stanford.edu/profiles/viewImage?facultyId=8212&type=bigger&showNoImage=true&lastModified=1336510958000Ronald Witteles, MD, Program Director

Dr. Witteles (Program Director) graduated from The University of Chicago Pritzker School of Medicine, and he completed all of the remainder of his training at Stanford -- including residency in Internal Medicine, a Chief Resident year, and fellowship in Cardiovascular Medicine. He is an active member of the Heart Failure faculty, and is a frequent attending on the CCU. His research and clinical interests include the cardiac effects of cancer therapy and amyloidosis, and he serves as Co-Director of the Stanford Amyloid Center.

 

http://med.stanford.edu/profiles/viewImage?facultyId=15195&type=bigger&showNoImage=true&lastModified=1338400998000Neera Ahuja, MD, Associate Program Director

Dr. Ahuja (Associate Program Director) completed her medical school education and residency in Internal Medicine/Pediatrics at the University of Texas Health Science Center in Houston. She has served as a program director in Texas before joining Stanford in 2009 as an associate program director, and hence bringing several years of experience in medical education to our residency program. In addition, she serves as the Director of the Stanford Hospitalist Program, a group whose clinical, quality improvement, and educational efforts are intimately tied to housestaff education.

 

stephanieharmonmdStephanie Harman, MD, Associate Program Director

Dr. Harman (Associate Program Director) graduated from Case Western Reserve University School of Medicine. She then completed a residency in Internal Medicine at Stanford and a Palliative Care fellowship in the joint Palo Alto VA/Stanford program. She is an active member of the palliative medicine faculty and is medical director of the Stanford Palliative Care service. Her research and educational interests include teaching communication skills and bioethics in end-of-life care.

 

http://med.stanford.edu/profiles/viewImage?facultyId=8255&type=bigger&showNoImage=true&lastModified=1335374034582Cybele Renault, MD, Associate Program Director- VA

Dr. Renault (Associate Program Director at the Palo Alto VA) completed medical school and her Internal Medicine residency at The University of Chicago, and came to Stanford for her Infectious Diseases fellowship after spending a year as Chief Resident at John H. Stroger, Jr. Hospital of Cook County in Chicago. At the VA, she practices infectious diseases and attends on the general medicine wards. She has a particular interest in working with underserved populations and in global health, where she is the head of the Johnson & Johnson rotation at Mulago Hospital in Uganda, is Co-Director of the annual Stanford 2-week Intensive Global Health Course, and is intimately involved with the Internal Medicine Global Health Track.

 

abrahamvergheseAbraham Verghese, MD, Senior Associate Chair for the Theory and Practice of Medicine

Dr. Verghese (Senior Associate Chair for the Theory and Practice of Medicine) graduated from Madras University Medicine, India. He completed his residency in Internal Medicine and Fellowship at East Tennessee State University Medicine. He is an accomplished author with bestselling fiction and nonfiction nooks incorporating the art of practice of medicine. He pioneered the Stanford Medicine 25, a collection of technique-dependent bedside skills which all of Stanford residents learn.

 

PortraitJeffrey S. Glenn, MD, PhD., Co-Director, Clinical Investigator Pathway

Jeffrey Glenn is an Associate Professor of Medicine (Division of Gastroenterology & Hepatology) and Microbiology & Immunology, the Director of the Center for Hepatitis and Liver Tissue Engineering, and co-director of the Stanford Clinical Investigator Pathway program. He also heads a research laboratory focused on studying molecular virology and the translation of that knowledge into novel antiviral strategies, as well as the development of new models with which to study hepatitis viruses and liver diseases.
He received his B.A. degree in Biochemistry and French Civilization from U.C. Berkeley from where he graduated summa cum laude. He received his M.D. and Ph.D. in Biochemistry and Biophysics from U.C.S.F.. He trained in internal medicine at Stanford University where he completed specialty training in gastroenterology, and joined the faculty in 2000.

 

LindaBoxerLinda Boxer, MD, PhD., Vice Dean of the School of Medicine and Professor of Medicine, Co-Director, Clinical Investigator Pathway

Dr. Boxer (Senior Vice Chair) has a long-standing interest in training physician scientists and academic leaders. Dr. Boxer is a physician scientist and a clinical hematologist. She graduated from Stanford University School of Medicine with MD and PhD degrees and was an intern and resident at Stanford. After completing hematology and oncology fellowships at Stanford, she joined the faculty in the Division of Hematology in 1990. She has directed the Stanford Clinical Investigator Pathway since 2004 and was the hematology fellowship director for 8 years. She is Senior Vice Chair of the Department of Medicine and Chief of the Division of Hematology.

 

robertharringtonmdRobert Harrington, MD, Department of Medicine Chair

Dr. Robert Harrington is Arthur L. Bloomfield Professor of Medicine and Chairman of the Department of Medicine at Stanford University. Dr. Harrington was previously the director of the Duke Clinical Research Institute (DCRI). His research interests include evaluating antithrombotic therapies to treat acute ischemic heart disease and to minimize the acute complications of percutaneous coronary procedures, studying the mechanism of disease of the acute coronary syndromes, understanding the issue of risk stratification in the care of patients with acute ischemic coronary syndromes, trying to better understand and improve upon the methodology of clinical trials.

He has authored more than 400 peer-reviewed manuscripts, reviews, book chapters, and editorials. He is an associate editor of the American Heart Journal and an editorial board member for the JACC. He is a senior editor of the 13th edition of Hurst’s The Heart. He recently served as a member and the chair of the Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee.

 

 

 

 

 

Stanford Medicine Resources:

Footer Links: